Atrial fibrillation, shared decision making, and the prevention of stroke

Stroke

Volumn 33, Issue 1, 2002, Pages 243-244

  McAlister, Finlay A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULANT THERAPY; DRUG INDUCED DISEASE; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL DECISION MAKING; NOTE; PATIENT ATTITUDE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; STROKE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; DECISION MAKING; HUMANS; PATIENT PARTICIPATION; WARFARIN;

EID: 0036142670     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Why do patients with atrial fibrillation not receive warfarin?
2. Decision analysis and guidelines for anticoagulant therapy to prevent strokes in patients with atrial fibrillation
3. The impact of patients' preferences on the treatment of atrial fibrillation: Observational study of patient based decision analysis
4. Cost-effectiveness of preference- based antithrombotic therapy for patients with nonvalvular atrial fibrillation
5. Sharing decisions with patients: Is the information good enough?
6. Informed decision making in outpatient practice: Time to get back to basics
7. Physicians' perceptions of the benefits and risks of warfarin for patients with non-valvular atrial fibrillation
8. Decision aids for patients facing health treatment or screening decisions: Systematic review
9. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation